Long-Term Report of a Comprehensive Molecular and Genomic Analysis in NRG Oncology/RTOG 0424: A Phase II Study of Radiation and Temozolomide in High-Risk Grade II Glioma Oncology trials that used ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback